Abbisko Cayman Limited

Abbisko Cayman Limitedverified

2256.HK

Price:

$13.24

Market Cap:

$7.90B

Abbisko Cayman Limited, a clinical-stage biopharmaceutical company, discovers and develops small molecule oncology therapies in the People's Republic of China. Its product candidates are primarily small molecules that focus on small molecule precision oncology and small molecule immuno-oncology therapeutic areas. The company's primary product candidates are ABSK011, a small molecule inhibitor of fibroblast growth factor receptor 4 for the treatment of advanced hepatocellular carcinoma with hyper-activation of FGF19/FGFR4 signaling; and ABSK091, a molecularly targeted product candidate for the treatment of multiple solid tumors, including urothelial cancer, gastric cancer, cholangiocarcinoma,...[Read more]

Industry

Biotechnology

IPO Date

2021-10-13

Stock Exchange

HKSE

Ticker

2256.HK

The PE Ratio as of December 2025 (TTM) for Abbisko Cayman Limited (2256.HK) is 52.96

According to Abbisko Cayman Limited’s latest financial reports and current stock price. The company's current PE Ratio is 52.96. This represents a change of 6.63% compared to the average of 0.79 of the last 4 quarters.

Abbisko Cayman Limited (2256.HK) Historical PE Ratio (quarterly & annually)

How has 2256.HK PE Ratio performed in the past?

The mean historical PE Ratio of Abbisko Cayman Limited over the last ten years is 5.02. The current 52.96 PE Ratio has changed 105.49% with respect to the historical average. Over the past ten years (40 quarters), 2256.HK's PE Ratio was at its highest in in the June 2025 quarter at 9.14. The PE Ratio was at its lowest in in the March 2020 quarter at -35.14.

Quarterly (TTM)
Annual

Average

5.02

Median

-4.25

Minimum

-58.20

Maximum

108.01

Abbisko Cayman Limited (2256.HK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Abbisko Cayman Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 266.11%

Maximum Annual PE Ratio = 108.01

Minimum Annual Increase = -2277.74%

Minimum Annual PE Ratio = -58.20

Quarterly (TTM)
Annual
YearPE RatioChange
2024108.01-2277.74%
2023-4.9640.48%
2022-3.53266.11%
2021-0.96-90.60%
2020-10.26-82.37%

Abbisko Cayman Limited (2256.HK) Average PE Ratio

How has 2256.HK PE Ratio performed in the past?

The current PE Ratio of Abbisko Cayman Limited (2256.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

33.17

5-year avg

17.66

10-year avg

5.02

Abbisko Cayman Limited (2256.HK) PE Ratio vs. Peers

How is 2256.HK’s PE Ratio compared to its peers?

Abbisko Cayman Limited’s PE Ratio is greater than CARsgen Therapeutics Holdings Limited (-18.98), greater than Alphamab Oncology (47.00), greater than HBM Holdings Limited (35.67), greater than Ascletis Pharma Inc. (-42.10), greater than CStone Pharmaceuticals (-28.07), less than Nanjing Leads Biolabs Co Ltd (0), less than Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (76.68), greater than IVD Medical Holding Limited (21.59), greater than CK Life Sciences Int'l., (Holdings) Inc. (-29.00), greater than Lepu Biopharma Co., Ltd. (-57.83),

Build a custom stock screener for Abbisko Cayman Limited (2256.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abbisko Cayman Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Abbisko Cayman Limited (2256.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Abbisko Cayman Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Abbisko Cayman Limited's PE Ratio?

How is the PE Ratio calculated for Abbisko Cayman Limited (2256.HK)?

What is the highest PE Ratio for Abbisko Cayman Limited (2256.HK)?

What is the 3-year average PE Ratio for Abbisko Cayman Limited (2256.HK)?

What is the 5-year average PE Ratio for Abbisko Cayman Limited (2256.HK)?

How does the current PE Ratio for Abbisko Cayman Limited (2256.HK) compare to its historical average?